September 2026
The global oncolytic virus-based gene therapy market is growing rapidly as viral vectors are engineered to selectively target and destroy cancer cells.
September 2026
The global cell and gene therapy market size was calculated at USD 10.44 billion in 2026 and is projected to surpass around USD 47.18 billion by 2035 with a solid CAGR of 18.1%.
September 2026
The global cell and gene therapy quality control and analytics market is expanding with growing demand for robust testing, validation, and compliance in advanced therapies.
September 2026
The global gene therapy market size was exhibited at USD 13.24 billion in 2026 and is predicted to hit around USD 63.52 billion by 2035 with a solid CAGR of 19.09%.
September 2026
The global allogeneic cell therapy devices market size is projected to hit around USD 4,565.79 million by 2035 from USD 511.30 million in 2025 with a CAGR of 24.48%.
September 2026
The cell and gene therapy manufacturing market size is predicted to hit around USD 122.86 billion by 2034 from USD 18.06 billion in 2026, with a CAGR of 26.62%.
September 2026
The global cell and gene therapy bioanalytical testing services market size is expected to hit around USD 1,113.86 million by 2034 from USD 632.03 million in 2026, with a CAGR of 7.34%.
September 2026
The automation, digitization and robotics in cell and gene therapy manufacturing market reached USD 1,127.65 million in 2026, with key automation, digitization and robotics in cell and gene therapy manufacturing market companies including Thermo Fisher Scientific Inc., Sartorius AG, Danaher Corporation (Cytiva), Lonza Group AG.
September 2026
The global viral vectors based gene therapy for non-human primates market size is estimated to hit around USD 5.46 billion by 2034 from USD 1.3 billion in 2024, with a CAGR of 15.44%.
September 2026
The US cell and gene therapy market generated USD 4.74 billion in 2026, with prominent US cell and gene therapy market companies including Alnylam Pharmaceuticals Inc., Amgen Inc., Biogen Inc., CORESTEM Inc.
August 2026
The global cell and gene therapy clinical trials market size is projected to hit around USD 54.29 billion by 2034 from USD 13.32 billion in 2024 with a CAGR of 15.09%
July 2026
The cell and gene therapy market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries.
July 2026
The cell and gene therapy patient access and reimbursement market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries..
July 2026
The single dose gene therapy market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries.
June 2026
The global oncolytic virus therapy market size is evaluated at USD 3.71 billion in 2025 and is predicted to hit around USD 12.31 billion by 2035, growing at a CAGR of 12.74%.
June 2026
The global AAV gene therapy market size was evaluated at USD 2.85 billion in 2025 and is predicted to hit around USD 27.41 billion by 2035, with a CAGR of 25.39%.
May 2026
The global gene-replacement therapy market analysis covers market size, growth drivers, key players, pipeline advances, and regulatory trends shaping future demand.
April 2026
The cancer gene therapy market size was estimated at USD 4.14 billion in 2025 and is projected to hit around USD 22.32 billion by 2035 with a CAGR of 18.35%.
July 2025
The global cell and gene therapy CDMO market size is estimated to hit around USD 74.03 billion by 2034 increasing from USD 10.33 billion in 2026, with a CAGR of 27.92%.
July 2025
The global nucleic acid therapeutics market size reached USD 5.77 billion in 2024 and is projected to surpass around USD 17.02 billion by 2034 with a solid CAGR of 11.42%.
September 2026
The global general anesthesia drugs market size was calculated at USD 5.81 billion in 2026 and is projected to surpass around USD 8.06 billion by 2035, with a CAGR of 3.71%.
September 2026
The photothermal therapy patches market size stood at USD 295.83 billion in 2026, with major photothermal therapy patches market companies including Photothermal Therapeutics Inc., NanoHybrids Inc., BioCure Technology Inc.
September 2026
The global hormone replacement therapy market size is projected to hit around USD 70.63 billion by 2035 from USD 42.02 billion in 2026 with a notable CAGR of 5.95%.
September 2026
The global shock wave therapy market size is calculated at USD 2.57 billion in 2026 and is projected to hit around USD 6.48 billion by 2035 with a CAGR of 10.82%.
September 2026
The global electrosurgical generators market size reached USD 2.1 billion in 2026 and is estimated to hit around USD 4.03 billion by 2035 with a CAGR of 7.53%.
September 2026
The global radiotherapy market size is calculated at USD 9.10 billion in 2026 and is projected to hit around USD 15.56 billion by 2035 with a CAGR of 6.16%.
September 2026
The global epigenetics drugs and diagnostic technologies market size is estimated to hit around USD 79.03 billion by 2035 increasing from USD 23.13 billion in 2026, with a CAGR of 14.63%.
September 2026
The molecular cytogenetics market size reached USD 3.20 billion in 2026, with leading molecular cytogenetics market companies including Thermo Fisher Scientific, Illumina, Danaher, Roche Diagnostics.
September 2026
The global AI comic generator market size is estimated to hit around USD 271.06 billion by 2035 increasing from USD 40.74 billion in 2026, with a CAGR of 23.44%.
September 2026
The global user generated content platform market size was evaluated at USD 9.64 billion in 2026 and is predicted to hit around USD 117.24 billion by 2035, growing at a CAGR of 32.00%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com